Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer...
المؤلفون الرئيسيون: | Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A |
---|---|
مؤلفون آخرون: | International College of Geriatric Psychoneuropharmacology |
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
John Wiley & Sons, Ltd.
2010
|
الموضوعات: |
مواد مشابهة
-
Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
حسب: Oulhaj, A, وآخرون
منشور في: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
حسب: Smith, A, وآخرون
منشور في: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
حسب: de Jager, C, وآخرون
منشور في: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
حسب: De Jager, C, وآخرون
منشور في: (2012) -
Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
حسب: Goodwin, G
منشور في: (2003)